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AbSTrACT
Background: Ships should carry mandatory given amounts of medicinal products and basic first aid items, 
collectively known as the ship’s medicine chest. Type and quantities of these products/items are sugge-
sted by the World Health Organisation (WHO) and regulated by individual flag states. In countries that lack 
national legislation, it is assumed that ships should follow WHO indications. An objective difficulty mainly 
involving vessels of international long-haul routes could be to recognise medicinal compounds obtained 
in other countries for replacing products used or expired. Language barrier may complicate, if not make 
it impossible to interpret the name of the medicinal product and/or of the active principle as indicated 
in a box printed in a completely different language. Handling of the ship’s pharmacy may be difficult in 
case of purchasing of drugs abroad due to language barriers. Medicinal products are identified by the 
international non-proprietary name of the active principle and/or by their chemical or invented (branded) 
names. This may make the identification of a medicinal product difficult, primarily if it is purchased abroad 
and the box and instructions are written in the language of the country where it is marketed. Therefore, 
there is a simpler classification system of the medicinal compounds the ATC (ATC: Anatomy, Therapeutic 
properties, Chemical, pharmacological properties). This paper has reviewed the list of medicinal products 
recommended by WHO and assigned to each one the ATC code as a solution to the problem of medicinal 
compounds organisation. 
Materials and methods: Two researchers independently examined the list of medicinal compounds indicated 
in the third edition of the International Medical Guide for Ships and attributed to each compound the ATC 
code according to the 2013 Guidelines for ATC classification and Defined Daily Dose (DDD) assignment.
Results: The ATC code was attributed to the medicinal compounds indicated in the third edition of the 
International Medical Guide for Ships.
Conclusions: The availability of an objective system to identify medicinal products is required for ships, 
which will contribute in making the identification of items purchased simpler, making it easier to understand 
which drug seafarers need to be administer, and consequently reduce possible therapeutic mistakes.
(Int Marit Health 2017; 68, 1: 39–45)
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INTrOduCTION
The provision of good quality medical care for people 
on board seagoing vessels still represents a challenge for 
medicine as the majority of vessels do not have a doctor or 
adequately trained paramedic personnel on board. On the 
other hand, ships are at sea for days or weeks before they 
can reach a port. In this situation, the best possibility for 
treating diseases or injuries is to provide medical advices 
via telecommunication systems, to guarantee adequate 
training of personnel with the responsibility of health care 
on board and to have an adequate supply of medicinal 
products and medication items [1, 2]. Medicines and med-
ical equipment available on board of a ship constitute the 
so-called “medicine chest”. Although, at present, in larger 
ships the medicine chest is no longer a chest, but rather 
a small pharmacy with a variety of medicinal products and 
medical devices, the name has remained in memory of the 
box containing some of the therapeutic aids of the past, that 
was kept on board, centuries ago by the captain, paramedics 
or physicians. The United States of America were probably 
the first country to mandate in 1790, that every American 
flag vessel over 150 tons with a crew of ten should to carry 
a medicine chest [3]. In the nineteenth century, probably 
in relation to the significant increase in maritime traffic, 
various states began to regulate the matter of hygiene on 
board ships. Some countries started to prescribe the pres-
ence of a medicine chest on ships. International regulations 
were introduced with the international health conference 
held in Paris at the end of 1851 [4]. This meeting lead to 
an agreement in force of which the contracting states un-
dertook to check the hygienic condition of the vessels, the 
food ration, the health of the crew, and the presence of the 
“chest for medicinal products” with, attached, instructions 
for their use [4]. In a global world and taking into account 
that shipping is per se an international activity, the best 
solution is to approach the problem of the provision of the 
medical chest with a global view and commence efforts for 
the harmonisation of the contents of the ship pharmacy as 
much as possible. Ships should carry compulsorily given 
amounts of medicinal products and medication items. Type 
and quantities of these products/items are established 
by flag state regulations. The first attempt to address the 
problem of providing international ships with a minimum 
supply of medicinal products and medication items come 
from the World Health Organisation (WHO). In collaboration 
with the International Labour Office (ILO) WHO published in 
1967, the first edition of the International Medical Guide for 
Ships with a final appendix in which the minimum provision 
of medicinal products required to be on board of all the 
world’s ships was indicated. This list was updated in 1988 
with the second edition of the International Medical Guide 
for Ships [5] and in 2008, with the third and last edition 
of the same book [6, 7]. Lacking national regulations, it is 
assumed that ships should follow WHO indications. Besides 
the discussion on the quality and quantity of medicines and 
medication items should be available on board ships [8], 
another practical problem especially for vessels involved 
in international long-haul routes could be to recognise me-
dicinal products obtained in other countries for replacing 
products utilised or expired. Language barrier may compli-
cate, if not make it impossible to interpret the name of the 
medicinal product and/or of the active principle as indicated 
in a box printed, in a completely different language. This is 
due to lack of a precise indication system to recognise the 
same pharmaceutical product in any part of the world. This 
is why the best solution of this problem could be the use, for 
the contents of ship medical chest, an accurate indication 
system such as the ATC code (The Anatomical Therapeutic 
Chemical Classification System) [9, 10]. The ATC is a clas-
sification system of drugs maintained by the Nordic Council 
on Medicine and WHO/WHO Collaborating Centre for Drug 
Statistics Methodology of Uppsala (Sweden) [9]. In the ATC 
system drugs are divided into several groups according to 
the target organ, the mechanism of action and chemical 
and therapeutic characteristics [11]. In this work we have 
attributed the ATC code to the medicinal products of the 
WHO list for making identification and storage of products 
irrespective of the country where they were obtained, sim-
pler and efficient.  
MATerIAlS ANd MeTHOdS
The ATC classification system is based on the principle 
that each pharmaceutical product is associated with a single 
code. The drugs, therefore, must be classified according to 
their main therapeutic use. In the ATC system the drugs are 
divided into different groups according to the target organ, 
the mechanism of action and chemical and therapeutic 
characteristics [11]. Each main group is divided into five 
hierarchical levels as detailed in Table 1.
Based on the target organ of a therapeutic action, the 
ATC Anatomical Main Group is divided into 14 “Anatomical 
Main Groups” each indicated by a letter identifying the 
apparatus or system of organs on which the drug exerts 
its therapeutic action according to alphabetical order. The 
categories are listed in Table 2.
Two researchers independently (first analysis team) 
examined the list of medicinal compounds indicated in the 
third edition of the International Medical Guide for Ships [6] 
and attributed to each compound the ATC code according to 
the 2013 Guidelines for ATC classification and Defined Daily 
Dose (DDD) assignment [11] and the centralised human 
medicinal product by ATC code of the European Union [12]. 
A drug, however, can be used for two or more therapeutic 
indications of equal importance and this leads to different al-
www.intmarhealth.pl 41
Seyed Khorsow Tayebati et al., WHO ship’s medicine chest contents ATC classification codes
Table 1. The five hierarchical levels of the ATC classification system
level Groups Characteristic
I The ANATOMIC GROUP Characterised by a letter of the alphabet
II GROUP THERAPY Characterised by a 2-digit number
III SUB THERAPEUTIC Characterised by a letter of the alphabet
IV SUB CHEMICAL/THERAPEUTIC Characterised by a letter of the alphabet
V SUB CHEMICAL Characterised by a 2-digit number specific to each chemical
Table 2. Categories further dividing the ATC Anatomical Main 
Group based on the therapeutic action on the target organ
A Alimentary tract and metabolism
B Blood and blood-forming organs
C Cardiovascular system
D Dermatological
G Genito-urinary system and sex hormones
H Hormonal preparations, excluding sex hormones
J Anti-infectives for systemic use
L The antineoplastic and immunomodulating agents 
M Musculoskeletal system
N Nervous system
P Antiparasitic, insecticides and repellents
R Respiratory system
S Sensory organs
V Various
ternatives for its classification. A drug may also be provided 
in two or more dosages or pharmaceutical forms for different 
therapeutic uses: the actual therapeutic use in such cases 
will determine the classification. Preparations that cannot 
be unequivocally classified in a particular group are coded 
to a level IV with the letter X. For the classification of such 
ambiguous cases, two researchers (second analysis team), 
were involved in the evaluation and allocation of ATC code 
and in consensus with the first two researchers, and based 
on the actual main therapeutic use, they were assigned 
a proper ATC code.
reSulTS
The ATC codes of medicines prescribed by WHO to be 
made available on board ships are shown divided for therapeu-
tic classes. Table 3 summarises the ATC code for anti-inflam-
matory, anti-viral, anti-malarial drugs, antibiotic and anti-fungal 
agents. Table 4 indicates the ATC code for anti-allergic and 
anti-shock, cardiovascular and nervous system agents.
Table 5 lists the ATC codes for gastrointestinal, local 
anaesthetic, main analgesic, anti-haemorrhagic, anti-musca-
rinic, diuretic and hyperglycaemising agents recommended 
by WHO to be carried on board ships. The ATC codes of other 
drugs are indicated in Table 6. 
dISCuSSION 
The problem of provisions of medicinal products on 
board ships is not simple due to the diversity of laws and 
regulations on the distribution and use of medicinal prod-
ucts for different countries. Several countries have updated 
in the last years the content of the ship’s medicine chest 
for their own fleets [3, 13–16]. A comparative analysis of 
regulations and contents reveals significant non-homoge-
neity probably reflecting the different points of views in 
delivering assistance to patients. The international standard 
of the minimum provision of medicines that each ship must 
carry is reported as an appendix of the WHO International 
Medical Guide for Ships and the Medical First Aid Guide 
for use in Accidents Involving Dangerous Goods [6]. Ships 
usually undertake voyages, at times, far away from their own 
country for extended periods. Apart from the psychological 
problems that extended periods at sea, away from families 
can cause, the distance from the country of origin of the 
ship, which is common for vessels employed in international 
long-haul routes, can also cause problems in the supply of 
medicines for the ship’s pharmacy. Regularly prescribed 
medicinal products cannot be mailed abroad and therefore 
the only possibility to obtain medical supplies is to purchase 
them in a port where the ship lands. This situation makes 
some practical problems for the handling agent to purchase 
medicines at a local pharmacy, to acquire same product 
required by the flag state of the ship or the difficulty, if not 
the impossibility for the seafarers to understand what me-
dicinal compounds, are present inside the newly obtained 
medicines. For instance, medicinal products obtained in 
other countries with indications in foreign languages that 
the ship’s officer may not be able to understand. As an ex-
ample, extensively used, anti-hypertensive drug nifedipine 
in Chinese is ‘硝苯地平’, in Greek is ‘νιφεδιϖίνη’, in Russian 
is ‘нифедипин’, in Persian ‘نیفدیپین’. In this regard, 
if the supplier is not careful in providing indications in En-
glish or in the language of the ship’s country, identification 
of a compound purchased abroad can be extremely diffi-
cult. Medicinal products are identified by the international 
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Table 3. ATC codes for anti-inflammatory, anti-viral, anti-malarial drugs, antibiotic and anti-fungal agents
Generic name Therapeutic group Possible trade names dosage form ATC COde V
Anti-inflammatory drugs
Acetylsalicylic acid Analgesic, anti-inflammatory Aspirin, Aspro Tablet 300 mg N02BA01
Ibuprofen Anti-inflammatory, antirheumatic 
non steroids
Advil, Actifen, Genpril,  
Haltran, Medipren, Brufen
Coated tablet 400 mg M01AE01
Paracetamol
Acetaminophen
Anti-fever and antalgic Tylenol, Panadol Tablet 500 mg N02BE01
Hydrocortisone 1% cream Anti-inflammatory and  
anti-allergic
NA Cream D07AA02
Prednisone Corticosteroids for systemic use Prednisolone Tablet 25 mg H02AB07
Anti-viral drugs
Aciclovir Antiviral Zovirax, Acyclovir Tablet 400 mg J05AB01
Zidovudine plus Lamivudine Antiviral (HIV) Combivir Tablet 300 mg + 150 mg J05AR01
Anti-malarial drugs
Artemether Anti-malarial Larither Ampoule 1 mL = 80 mg P01BE02
Artemether + Lumefantrine Anti-malarial Riamet Tablets 2 mg + 120 mg P01BF01
Antibiotic and anti-fungal agents
Amoxicillin + clavulanate Antibiotic Augmentin, co-amoxyclav Tablet 875 mg/125 mg J01CR02
Azithromycin Antibiotic Zithromax Tablet 500 mg J01FA10
Ceftriaxone Antibiotic Rocephin Ampoule 1 g powder  
for injection (dissolve  
in water for injection)
J01DD04
Ciprofloxacin Antibiotic Ciproxin, Cipro Tablet 250 mg J01MA02
Mebendazole Anthelmintic, remedy for  
intestinal worms
Vermox Tablet 100 mg P02CA01
Metronidazole Antiprotozoal Flagyl Tablet 500 mg P01AB01
Miconazole 2% cream Antifungal Daktarin, Dermacure, 
Monistat
Cream A01AB09
Tetracycline 1% ointment Antibiotic NA Ointment S01AA09
Doxycycline Antibiotic with broad-spectrum 
antibacterial activity
Neo-Dagracycline, Unidox, 
Vibra-S, Vibramycine, Doryx
Tablet 100 mg J01AA01
NA — not available
non-proprietary name of the active principle and/or by their 
chemical or invented (branded) names. The list of WHO [6] 
as well as the majority of flag states national lists [3, 13, 
15–19] indicates medicinal products to be on board by the 
name of the active principle. Some explanations and brand 
names of the most common medicines are also elaborated 
[6, 17, 19]. Other lists such as the Norwegian, are more ge-
neric and indicate the categories of drugs required, without 
specific indication of names of medicinal compounds [14]. 
All these instructions are usually self-explanatory, but have 
the limitation in the correspondence, in case a medicine 
which has consumed or expired, and has to be replaced 
with another one obtained abroad. This apparently difficult 
situation can be easily solved, if that is the one next to the 
generic name of the active ingredient which is international, 
as used throughout the world, the addition of the ATC code 
definitely increase security. In this way they will avoid many 
identification errors, often due also to lack of clarity in the 
international treaties which should serve as a reference. As 
a reference to this point “paracetamol” that in International 
Medical Guide for Ships third edition is also labelled as acet-
aminophen, on the contrary generic name of the drug known 
as paracetamol in Europe is referred to as acetaminophen 
in the United States and Canada. The ATC classification 
system is based on the principle that each pharmaceutical 
preparation is associated with a single code and drugs are 
classified according to their main therapeutic use. In case a 
drug can be used for two or more therapeutic indications of 
equal importance, this leads to different alternatives for its 
classification. A drug may also be provided in two or more 
dosages or pharmaceutical forms for different therapeutic 
uses: the actual therapeutic use in such cases will deter-
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Table 4. ATC codes for anti-allergic and anti-shock, cardiovascular and nervous system agents
Generic name Therapeutic group Possible trade names dosage form ATC COde V
Anti-allergic and anti-shock agents
Cetirizine Anti-histaminic, anti-allergic Zyrtec Tablet 10 mg R06AE07
Dexamethasone Anti-allergic, anti-asthmatic,  
anti-anaphylactic shock
Decadron Ampoule 4 mg/mL H02AB02
Salbutamol Anti-asthma, anti-chronic  
bronchitis, anti-emphysema
Albuterol, Ventolin,  
Proventil
Inhaler 0.1 mg/dose  
with volume spacer
R03AC02
Cardiovascular agents
Adrenaline Cardiac stimulants, anti-anaphylactic 
shock, anti-asthma
Epinephrine, Adrenaline 
1:1000
Ampoule 1 mL = 1 mg C01CA24
Isosorbide dinitrate Anti-angina and anti-cardiac failure Cedocard, Isordil Tablet 5 mg C01DA08
Metoprolol Anti-hypertension; anti-  
-atrial fibrillation 
Selokeen, Lopresor,  
Toprol XL, Betaloc
Tablet 100 mg C07AB02
Nervous system agents
Diazepam Anxiolytic Valium Tablet 5 mg N05BA01
Midazolam Anxiolytic Hypnovel Ampoule 1 mL = 5 mg N05CD08
Haloperidol Antipsychotic Haldol Ampoule 1 mL = 5 mg N05AD01
mine the classification [11, 12]. The preparations which 
cannot be unequivocally classified in a given group are 
encoded to a level IV with the letter X. A medicinal product 
may be used for two or more equally important indications, 
and the main therapeutic use of a drug may differ from one 
country to another. This will often give several classification 
alternatives. Such drugs are usually only given one code, the 
main indication being decided on the basis of the available 
literature. For example, the preparations of nifedipine are 
classified with C08CA05 code, where: C indicates the car-
diovascular system (level I), C08 — calcium (level II), C08C 
— selective calcium antagonists with predominant vascular 
effects (level III), C08CA — dihydropyridine derivatives (level IV) 
and C08CA05 — nifedipine (level V). Pharmaceuticals are 
classified on the basis of main therapeutic use, following 
the principle that all similar formulations, comparable to 
ingredients, unit dose and route of administration, may have 
only one ATC code. The indication of the ATC code in the 
list of medicinal compounds required to be on board ships 
will offer the advantage not only of an easy identification 
of the product irrespective of the place where it has been 
obtained. It will be also useful to place a proper order of 
a given medicinal compound when stocks have been sold 
or expired. Moreover, the identification through ATC system 
also facilitates the initiation of a review of the contents of 
the medicine chest given by the WHO in International Med-
ical Guide for Ships third edition. ATC attribution queues 
could justify or contradict, the presence of some active 
principles using the system. For example misoprostol, as 
can be seen from the ATC code: A02BB01, A refers to 
the prostaglandin analogue, primarily used to prevent and 
not treat gastric and duodenal ulcers and not simply as 
a prevention of postpartum haemorrhage, as indicated 
by International Medical Guide for Ships third edition. In 
addition to emergency physicians in the United States, the 
prevention and treatment of severe bleeding after childbirth 
is an off-label in the sea, child-birth is very rare on the sea 
and therefore the presence of this drug in this indication 
makes little relevance. Vitamin K is also another example 
of a drug included by International Medical Guide for Ships 
third edition for its use as a haemostatic in case of bleeding 
caused by the use of warfarin (anticoagulant), although 
warfarin is rarely used in the ships, which also makes the 
presence of vitamin K on board ships questionable. At the 
present the only flag state national list reporting besides 
to the classic list per therapeutic principle the ATC code is 
the is Italian one [20]. This represents a real progress and 
a relevant effort for making handling of the ship’s pharmacy 
easier and more effective. 
An alternative strategy to ATC code, due to the difficulty 
for seafarers, who often lack proper technical prowess of 
ATC code interpretation, could be achieved by replacing in 
the computer each letter that makes up the specific ATC 
code (from A to Z) with a two-digit number based on its 
position in the alphabet: A = 01, B = 02, C = 03, D = 04 
........V = 22, Z = 26, so that each ATC code becomes a nu-
meric sequence of ten digits. In this way, for example, parac-
etamol, whose ATC code is NO2BE01 would be assigned 
the new code 1402020501. This identification strategy 
can be used only within the same company, as pharmacists 
around the world will have no familiarity with the system. 
Such a system has been used successfully for years by 
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Table 5. ATC codes for gastrointestinal, local anaesthetic, main analgesic, anti-haemorrhagic, anti-muscarinic, diuretic and  
hyperglycaemising agents
Generic name Therapeutic group Possible trade names dosage form ATC COde V
Gastrointestinal agents
Ondansetron Anti-vomiting, anti-seasickness Zofran Tablet 4 mg A04AA01
Sodium chloride  
0.9% infusion
Liquid replacement NaCl 0.9%, saline solution Plastic bottle, 1 L A12CA01
Loperamide Antidiarrheal Imodium, Diacure Tablet 2 mg A07DA03
Oral rehydration salt Anti-dehydration in diarrhoea Repolyte, Gastrolyte,  
Dioralyte
Sachets of powder  
for reconstitution
A07CA
Omeprazole Anti-peptic ulcer, anti-gastro- 
-oesophageal, reflux
Losec, Prilosec Tablet 20 mg A02BC01
Docusate with Senna  
(or equivalent)
Anti-constipation Coloxyl Tablet 50 mg + 8 mg A06AG10
Local anaesthetic agents
Amethocaine 0.5%  
eye drops
Local anaesthetic Tetracaine Single-use vial 1 mL S01HA03
Lignocaine 1%  
(without adrenaline)
Local anaesthetic Xylocaine, Lidocaine Ampoule 5 mL N01BB02
Main analgesic agents
Morphine (injectable) Opioid analgesic (treatment  
severe pain)
NA Ampoule 1 mL = 10 mg N02AA01
Morphine (oral) Opioid Analgesic (treatment  
of moderate to severe pain)
NA Liquid 1 mg/mL N02AA01
Naloxone Antidote for opiate Narcan Ampoule 1 mL = 0.4 mg V03AB15
Anti-haemorrhagic agents
Misoprostol Prevent postpartum haemorrhage Cytotec Tablet 200 mg A02BB01
Vitamin K Anti-bleeding caused by the use of 
warfarin
Konakion, Phytomenadione Ampoule 1 mL = 10 mg B02BA01
Anti-muscarinic agents
Atropine Ophthalmologicals, mydriathics  
and cycloplegics
NA Ampoule 1.2 mg/mL S01FA01
Diuretic agents
Frusemide Diuretic Lasix, Furosemide Ampoule 4 mL = 40 mg C03CA01
Hyperglycaemising agents
Glucagon, ready to use Glycogenolytic (used in severe  
hypoglycaemic crisis)
Glucagen Ampoule 1 mg H04AA01
NA — not available
some cruise companies which lists of medication are far 
more extensive than the WHO list. In these cases, the drugs 
have been listed through their ATC codes to 10 digits, ac-
cordingly, ships of the same company have their medicines 
organised in a uniform manner. Of course, introduction of 
such a new identification system of medicinal compounds 
on ships would require agreements and issuing guidelines 
from authoritative sources.  
CONCluSIONS
In this paper we have added the international ATC code 
to the WHO list of medicinal products to be present on board 
ships [6]. This alphanumeric code will allow the purchase 
and identification of a product in any country of the world 
without the need to know the brand name of the drug that 
may be different from country to country. The adoption of 
a classification system such as the ATC by all national flag 
states would allow seafarers on any ship finding, in whatev-
er country they are, necessary medications. This will allow 
moving towards a more universal system of classification 
of medicinal compounds for the ship’s medicine chest. Last 
but not least, the adoption of this international standard 
will allow efficient organisation of the contents of the ship’s 
medical chest by competent authorities without the need 
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Table 6. ATC codes for other (minor) agents not listed in Tables 3–5
Generic name Therapeutic group (e.u.) Possible trade names dosage form ATC COde V
Ethanol 70%, hand  
cleanser gel
Disinfectant (alternative 
hand washing)
NA Gel D08AX08
Ethanol 70%, liquid Disinfectant NA Liquid D08AX08
Charcoal, activated Ingested poisons absorbent NA 50 g in 300 mL purified water A07BA01
Permethrin 1% lotion Ectoparasiticides,  
scabicides
Loxazol, Elimite, Nix Lotion P03AC04
Permethrin 5% lotion Ectoparasiticides,  
scabicides
Lyclear Lotion P03AC04
Povidone iodine ointment 
10% and solution 10%
Anti-infectives and  
antiseptics
Betadine, Povidine Ointment, liquid G01AX11
Oxymetazoline 0.5%  
(or equivalent)
Nasal decongestion Drixine Drops R01AA05
Fluorescein 1%, strips Cornea damage detector NA NA S01JA01
Zinc oxide Protective for irritated skin NA Paste or ointment, 20% D02AB
NA — not available
of relatively high level pharmacological competence that 
could be not always available.  
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